Insider Selling: NeueHealth, Inc. (NYSE:NEUE) CEO Sells 16,803 Shares of Stock

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) CEO George Lawrence Mikan III sold 16,803 shares of the firm's stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54. Following the completion of the transaction, the chief executive officer now directly owns 83,029 shares in the company, valued at approximately $347,061.22. The trade was a 16.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

NeueHealth Price Performance

Shares of NEUE stock opened at $4.06 on Thursday. The stock has a market cap of $33.64 million, a PE ratio of -0.08 and a beta of 0.78. The stock has a 50-day moving average of $5.15 and a 200-day moving average of $5.26. NeueHealth, Inc. has a one year low of $3.99 and a one year high of $16.59.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reduced their price target on NeueHealth from $8.00 to $7.00 and set a "sector perform" rating on the stock in a research report on Monday, December 9th.

Read Our Latest Report on NEUE

Institutional Inflows and Outflows


URGENT: This Altcoin Opportunity Won’t Wait – Act Now
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin


A number of institutional investors have recently bought and sold shares of NEUE. Partners Group Holding AG bought a new position in shares of NeueHealth during the third quarter worth $463,000. Deer Management Co. LLC acquired a new stake in NeueHealth during the 2nd quarter worth $5,436,000. NEA Management Company LLC bought a new position in NeueHealth during the second quarter worth about $14,834,000. Renaissance Technologies LLC acquired a new position in NeueHealth in the second quarter valued at about $312,000. Finally, Pathway Capital Management LP bought a new stake in shares of NeueHealth in the second quarter worth about $61,000. Institutional investors and hedge funds own 63.88% of the company's stock.

NeueHealth Company Profile

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Read More

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at NeueHealth?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for NeueHealth and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles